Clinical Trials Browser

Esophageal Neoplasms

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Stomach Neoplasms

Urinary Bladder Neoplasms

Stomach Neoplasms

Oropharyngeal Neoplasms

Advanced Solid Tumour

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Cholangiocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Carcinoma, Non-Small-Cell Lung

Small Bowel Adenocarcinoma

Solid Tumors

Clinical Trials

PROTECT

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

EDGE-Gastric

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

DG-03

TOGAR

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies